Research graph
References from Vortex-actuated pre-enrichment accelerates human regulatory T cell sorting and improves early fitness. Local targets link to admitted publications; unresolved targets remain external evidence.
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials
10.1016/s0140-6736(20)30167-7 · 2020 · External reference
Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients
10.1111/ajt.16395 · 2021 · External reference
A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease
10.1182/bloodadvances.2021006625 · 2022 · External reference
Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease
10.1053/j.gastro.2012.07.116 · 2012 · External reference
Cell banking for regulatory T cell-based therapy: strategies to overcome the impact of cryopreservation on the Treg viability and phenotype
10.18632/oncotarget.23887 · 2018 · External reference
A GMP Protocol for the Manufacture of Tregs for Clinical Application
10.1007/978-1-0716-2647-4_14 · 2023 · External reference
Study Design: Human Leukocyte Antigen Class I Molecule A(∗)02-Chimeric Antigen Receptor Regulatory T Cells in Renal Transplantation
10.1016/j.ekir.2022.03.030 · 2022 · External reference
Donor antigen-specific regulatory T cell administration to recipients of live donor kidneys: A ONE Study consortium pilot trial
10.1016/j.ajt.2023.06.012 · 2023 · External reference
A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials
10.1016/j.omtm.2018.01.006 · 2018 · External reference
Methods to manufacture regulatory T cells for cell therapy
10.1111/cei.13297 · 2019 · External reference
Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation
10.1111/ajt.12433 · 2013 · External reference
Considerations for high-yield, high-throughput cell enrichment: fluorescence versus magnetic sorting
10.1038/s41598-018-36698-1 · 2019 · External reference
The efficiency of magnetic-activated cell sorting and fluorescence-activated cell sorting in the decontamination of testicular cell suspensions in cancer patients
10.1093/humrep/del418 · 2007 · External reference
Magnetic cell sorting and flow cytometry sorting methods for the isolation and function analysis of mouse CD4+ CD25+ Treg cells
10.1631/jzus.b0920205 · 2009 · External reference
Ex vivo expansion of CD4(+)CD25(+) T regulatory cells for immunosuppressive therapy
10.1002/cyto.a.20659 · 2009 · External reference
Effect of mitochondrial oxidative stress on regulatory T cell manufacturing for clinical application in transplantation: Results from a pilot study
10.1016/j.ajt.2024.10.024 · 2025 · External reference
Optimizing CAR-T Cell Manufacturing Processes during Pivotal Clinical Trials
10.1016/j.omtm.2019.11.018 · 2020 · External reference
Treg cell therapy: How cell heterogeneity can make the difference
10.1002/eji.201948131 · 2021 · External reference
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
10.1126/scitranslmed.aad4134 · 2015 · External reference
Selective decrease of donor-reactive T(regs) after liver transplantation limits T(reg) therapy for promoting allograft tolerance in humans
10.1126/scitranslmed.abo2628 · 2022 · External reference
Polyclonal Regulatory T Cell Manufacturing Under cGMP: A Decade of Experience
10.3389/fimmu.2021.744763 · 2021 · External reference
Clinical grade multiparametric cell sorting and gene-marking of regulatory T cells
10.1016/j.jcyt.2024.02.023 · 2024 · External reference
Comparison of electrostatic and mechanical cell sorting with limited starting material
10.1002/cyto.a.24523 · 2022 · External reference
CAR-T cell manufacturing landscape-Lessons from the past decade and considerations for early clinical development
10.1016/j.omtm.2024.101250 · 2024 · External reference
High-throughput genome-wide phenotypic screening via immunomagnetic cell sorting
10.1038/s41551-019-0454-8 · 2019 · External reference
In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes
10.1084/jem.20040139 · 2004 · External reference
Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity
10.1016/j.exphem.2011.08.010 · 2011 · External reference
Cell sorting actuated by a microfluidic inertial vortex
10.1039/c9lc00120d · 2019 · External reference
Extremely High-Throughput Parallel Microfluidic Vortex-Actuated Cell Sorting
10.3390/mi12040389 · 2021 · External reference
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
10.1002/eji.201970107 · 2019 · External reference
An Evaluation of T-Cell Functionality After Flow Cytometry Sorting Revealed p38 MAPK Activation
10.1002/cyto.a.23964 · 2020 · External reference
Methodological comparison of FACS and MACS isolation of enriched microglia and astrocytes from mouse brain
10.1016/j.jim.2020.112834 · 2020 · External reference
An evaluation of sorter induced cell stress (SICS) on peripheral blood mononuclear cells (PBMCs) after different sort conditions - Are your sorted cells getting SICS?
10.1016/j.jim.2020.112902 · 2020 · External reference
Flow cytometry and cell sorting
10.3389/fmed.2023.1287884 · 2023 · External reference
Translating microfluidics: Cell separation technologies and their barriers to commercialization
10.1002/cyto.b.21388 · 2017 · External reference
A method for high purity sorting of rare cell subsets applied to TDC
10.1016/j.jim.2013.10.002 · 2013 · External reference
